U.S., March 20 -- ClinicalTrials.gov registry received information related to the study (NCT07481526) titled 'A Prospecitve Multicenter, Observational Registry Study' on Feb. 13.
Brief Summary: This is a prospective, multicenter, observational registry study designed to collect data to deepen the understanding of CKD therapeutics, changes in clinical practice, cardiorenal risk outcomes and differences in treatment approaches in Chinese CKD patients.
Study Start Date: Feb. 27
Study Type: OBSERVATIONAL
Condition:
Chronic Kidney Disease
Recruitment Status: RECRUITING
Sponsor: AstraZeneca
Disclaimer: Curated by HT Syndication....